Prelude Therapeutics (PRLD) Accumulated Depreciation & Amortization (2024)
Historic Accumulated Depreciation & Amortization for Prelude Therapeutics (PRLD) over the last 1 years, with Q4 2024 value amounting to $5.3 million.
- Prelude Therapeutics' Accumulated Depreciation & Amortization changed N/A to $5.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $5.3 million, marking a year-over-year change of. This contributed to the annual value of $5.3 million for FY2024, which is N/A changed from last year.
- As of Q4 2024, Prelude Therapeutics' Accumulated Depreciation & Amortization stood at $5.3 million.
- In the past 5 years, Prelude Therapeutics' Accumulated Depreciation & Amortization registered a high of $5.3 million during Q4 2024, and its lowest value of $5.3 million during Q4 2024.